刺痛激进分子以及如何在癌症免疫疗法中充分发挥其潜力
Laura Gehrcken1, Christophe Deben1, Evelien Smits1
1Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, 2610, Belgium.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 27, 2025
概括
干扰素基因刺激剂 (STING) 激动剂通过激活对瘤的免疫反应,显示出癌症免疫治疗的潜力. 目前正在探索组合策略,以克服胰腺癌等固体瘤的抗性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物开发 药物开发
背景情况:
- 癌症仍然是导致死亡的主要原因,推动了对创新治疗的需求.
- 免疫疗法是有希望的,但由于"冷"的瘤微环境,它面临着固体瘤的抵抗.
- 干扰素基因 (STING) 激动剂正在开发中,以增强抗瘤免疫力.
研究的目的:
- 审查癌症免疫治疗中STING激动剂的新组合策略.
- 评估这些组合方法的好处和挑战.
- 探索STING激动剂在克服瘤耐药性的潜力.
主要方法:
- 对STING激动剂和组合疗法的临床前研究的审查.
- 对STING激动机制的分析,包括免疫细胞透和I型干扰素分泌.
- 检查临床翻译和新兴组合策略中的挑战.
主要成果:
- 刺痛激动剂可以触发癌症免疫循环,增加I型干扰素分泌和T细胞激活.
- 临床前研究表明,STING激动剂在诱导瘤回归方面取得了有希望的结果.
- 新兴的与其他免疫疗法的组合策略显示出令人鼓舞的临床前结果.
结论:
- 刺痛激动剂对对抗瘤的免疫系统进行重编程具有重大前景.
- 克服生物和物理挑战对于临床翻译至关重要.
- 组合策略是增强癌症免疫治疗中的STING激动剂疗效的有希望的途径.
相关概念视频
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K


